Pharmaceutical Compounding Techniques Guide

In an era of mass-produced medications, pharmaceutical compounding—the art and science of preparing personalized medications—remains a vital, patient-centered skill. It addresses unique clinical needs unmet by commercial products, from allergy-specific formulations to precise pediatric dosages. Mastering both non-sterile and sterile techniques is a cornerstone of advanced pharmacy practice, demanding unwavering precision, rigorous quality control, and strict adherence to evolving regulatory standards like USP Chapters <797> and <800>.

Non-Sterile Compounding: Capsules, Suspensions, and Topicals

Non-sterile compounding involves preparing medications that are not required to be free of all microorganisms. The three most common dosage forms are capsules, suspensions, and topical preparations.

Capsule preparation typically uses the punch method for small batches or a capsule machine for larger quantities. The key is ensuring uniform drug distribution. For powdered blends, you must employ geometric dilution: mix the active ingredient with an equal part of diluent, then add another equal part of diluent, repeating until all components are incorporated. This prevents the smaller quantity of active powder from being lost or unevenly distributed. For potent drugs, a trituration step—grinding powders together in a mortar and pestle—ensures a fine, homogeneous mixture before dilution.

Compounding suspensions—where solid particles are dispersed in a liquid vehicle—requires attention to particle size and stability. You must first reduce the drug powder to a fine particle size via trituration. Then, you incorporate it into the vehicle using a suspending agent like methylcellulose or a structured vehicle like Oral-Sweet SF. The final step is a levigation, where you mix the powder with a small amount of a non-solvent liquid (like glycerin or mineral oil) to form a smooth paste before adding to the main vehicle, preventing clumping.

Topical preparations include creams, ointments, gels, and pastes. The primary technique here is ointment slab and spatulation. You place the base (e.g., petroleum jelly) on an ointment slab and use a flexible spatula to incorporate the active ingredient(s). For incorporating solids, levigation is again essential. When combining two different semisolid bases, you must spatulate thoroughly to achieve a uniform consistency and drug distribution.

Sterile Compounding: USP <797> and USP <800> Requirements

Sterile compounding, governed by USP Chapter <797>, mandates the preparation of injections, ophthalmics, and other products free from viable microorganisms. The core environment is the ISO-Classified Cleanroom Suite, which includes an anteroom and a buffer area. Critical work is performed within a Primary Engineering Control (PEC), such as a laminar airflow workbench (LAFW) or a compounding aseptic isolator (CAI), which provides ISO 5 air quality.

The aseptic technique is the non-negotiable skill. This involves meticulous hand hygiene, proper garbing (gown, gloves, hair cover, face mask), and conscious avoidance of touching critical sites (e.g., syringe plunger tip, needle hub). All manipulations—vial entries, syringe transfers—must be performed within the laminar airflow of the PEC, with the worker taking care not to interrupt the airflow between the HEPA filter and the open sterile components.

USP Chapter <800> adds a critical layer for handling hazardous drugs (HDs), like chemotherapeutic agents. Its requirements are designed to protect personnel and the environment. Key mandates include: receiving HDs in a dedicated, negative-pressure area; storing them separately; and compounding them within a Containment Primary Engineering Control (C-PEC), typically a Class II or III Biological Safety Cabinet (BSC) or a compounding aseptic containment isolator (CACI). The C-PEC must be located within a Containment Segregated Compounding Area (C-SCA), which is negative-pressure relative to adjacent spaces. Deactivation, decontamination, and cleaning procedures are also strictly defined.

Beyond-Use Dating, Quality Control, and Documentation

Assigning an accurate beyond-use date (BUD) is a fundamental pharmacist responsibility. The BUD is not an expiration date but the date after which a compounded preparation should not be used. You determine it based on the shortest component stability, the preparation's chemical and physical stability, storage conditions, and the applicable default tables in USP <795> (non-sterile) and <797> (sterile). For sterile preparations, these defaults range from 12 hours to 45 days, depending on the compounding category (Immediate-Use, Low-Risk, Medium-Risk, High-Risk) and storage temperature.

Quality control (QC) testing is integral to verifying the safety and efficacy of every batch. For non-sterile compounds, this includes weight variation checks on capsules, pH testing for liquids, and visual inspection for uniformity. For sterile products, sterility testing is paramount, though it is a retrospective test. More immediate process validation is achieved through media-fill tests, where you simulate compounding using a sterile growth medium instead of drug product, then incubate it to detect any microbial contamination introduced during the procedure.

Comprehensive documentation is the backbone of a defensible compounding practice. Every compounded prescription must have a master formulation record and a compounding record. This log must include: patient information; names, strengths, and quantities of all components; calculations; lot numbers and expiration dates of ingredients; equipment used; assigned BUD; storage requirements; and the initials of the compounding pharmacist. For sterile products, you must also document cleanroom environmental monitoring results (particle counts, pressure differentials) and personnel aseptic technique media-fill results.

Equipment, Maintenance, and Business Considerations

Reliable compounding begins with properly maintained equipment. Calibration is a scheduled, documented activity. Analytical balances must be calibrated with certified weights daily or before each use. pH meters require calibration with standard buffer solutions before use. Preventive maintenance on equipment like ointment mills, capsule machines, laminar flow hoods, and biological safety cabinets is contractually scheduled and documented. For PECs and C-PECs, certification by an independent entity is required every six months to verify ISO 5 air quality, airflow velocity, and integrity.

Operating a compounding pharmacy involves distinct business considerations. You must navigate a complex reimbursement landscape, as many compounded medications are not covered by standard insurance formularies. Patient counseling becomes even more critical to ensure proper use and storage of custom medications. Furthermore, you must stay vigilant regarding federal and state regulatory changes, particularly from the FDA and state boards of pharmacy, which have increased scrutiny on office-use compounding and the use of bulk drug substances. Developing a robust quality assurance program is not just a regulatory requirement but a key business differentiator that builds trust with prescribers and patients.

Common Pitfalls

1. Inaccurate Weighing and Measuring: The most common source of error. Correction: Always use a calibrated balance appropriate for the weight required (use a high-precision balance for small masses). Never weigh directly on the balance pan; use a weighing boat or parchment. For liquids, use a graduated cylinder of appropriate size and read the meniscus at eye level.

1. Poor Aseptic Technique in Sterile Compounding: Reaching over open sterile components, touching critical sites, or working outside the laminar airflow zone. Correction: Practice deliberate, slow movements. Always keep open sterile items within the unobstructed laminar airflow zone, typically 6 inches within the hood. Perform a media-fill test quarterly to validate your technique.

1. Incorrect Beyond-Use Date Assignment: Using the longest component expiration date instead of a stability-based BUD. Correction: Always refer to USP <795> and <797> default BUD tables first. If you assign a longer BUD based on stability literature, you must have that documentation readily available and the rationale must be sound and scientifically supported.

1. Inadequate Documentation: Viewing the compounding log as an afterthought. Correction: Document concurrently with the compounding process. Every component, weight, and lot number must be recorded at the time it is used. Incomplete records are considered a violation of practice standards and make product integrity impossible to verify.

Summary

• Pharmaceutical compounding is a critical patient-care service that customizes medications, utilizing distinct techniques for non-sterile forms (capsules, suspensions, topicals) and sterile preparations requiring an aseptic environment.
• Sterile compounding is strictly regulated by USP Chapter <797> for sterility assurance and USP Chapter <800> for the safe handling of hazardous drugs, mandating specific engineering controls, work practices, and personal protective equipment.
• A scientifically determined beyond-use date (BUD), rigorous quality control testing, and immaculate documentation are legal and ethical imperatives for every compounded preparation.
• Maintaining a compliant operation requires scheduled calibration, preventive maintenance, and certification of all critical equipment, from balances to laminar airflow hoods.
• Successful compounding pharmacy practice balances clinical precision with astute business considerations, including regulatory compliance, reimbursement strategies, and a strong quality assurance program.